Cas:1255204-84-2 MK-7145 manufacturer & supplier

Chemical Name:MK-7145

CAS.NO:1255204-84-2

Synonyms:5,5′-[piperazine-1,4-diylbis(1-hydroxyethane-2,1-diyl)]bis(4-methyl-2-benzofuran-1(3H)-one);MK-7145;5,5′-((1R,1’R)-Piperazine-1,4-diylbis(1-hydroxyethane-2,1-diyl))bis(4-methylisobenzofuran-1(3H)-one);1(3H)-Isobenzofuranone,5,5′-(1,4-piperazinediylbis((1R)-1-hydroxy-2,1-ethanediyl))bis(4-methyl

Molecular Formula:C₂₆H₃₀N₂O₆

Molecular Weight:466.52600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:99.54000

Exact Mass:466.21000

LogP:1.90460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5,5′-[piperazine-1,4-diylbis(1-hydroxyethane-2,1-diyl)]bis(4-methyl-2-benzofuran-1(3H)-one) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1(3H)-Isobenzofuranone,5,5′-(1,4-piperazinediylbis((1R)-1-hydroxy-2,1-ethanediyl))bis(4-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1(3H)-Isobenzofuranone,5,5′-(1,4-piperazinediylbis((1R)-1-hydroxy-2,1-ethanediyl))bis(4-methyl Use and application,MK-7145 technical grade,usp/ep/jp grade.

Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. MK-7145 manufacturer A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). MK-7145 supplier Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. MK-7145 vendor Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. MK-7145 factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).